Comparison Between Magnetic Field and Laser Therapy in Management of Trigeminal Neuralgia

Delta University for Science and Technology120 enrolled

Overview

Trigeminal neuralgia (TN) was defined by The International Association for the Study of Pain (IASP) as severe, sudden, usually unilateral, stabbing, brief, recurrent attacks of pain in one or more distributional branches of the trigeminal nerve. The purpose of the current study will to investigate the effect of Low level laser therapy versus electromagnetic therapy on diabetic trigeminal neuralgia pain intensity and amplitude of the compound muscle action potential of the masseter and temporalis muscles in diabetic TN patients.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

120

Conditions

Trigeminal Neuralgia

Interventions

Electromagnetic therapy.OTHER

Electromagnetic therapy will be applied for 20 min/ session for (3 days/ week for two months) to the group intervention.

Low level laser therapy (LLLT)OTHER

Low level laser therapy (LLLT) will be applied for 20 min/session laser scanner for three days each week for two months to the group intervention.

Eligibility

Sex: ALLMin age: 25 YearsMax age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All participants will between the ages of 25 and 45, will of both sexes (male and female), diabetic type two patients with chronic trigeminal neuralgia, (from three to six months). * Patients will awake, cooperative, and free of psychiatric issues (as determined by a psychologist) as well as difficulties resulting from orthopaedic or special sensory deficits. Exclusion Criteria: * Patients will ruled out if they developed TN due to a tumour, herpes zoster, or any other reason other than diabetes, such as significant coagulation dysfunction, cardiopulmonary dysfunction or previous invasive treatment (ethanol, radiofrequency, Gama-knife microvascular decompression, glycerinum injection). * They will not have a previous disability in the face.

Locations (1)

AAA

Cairo, Egypt

Outcomes

Primary Outcomes

Studies using electromyography and complex muscle action potentials

All patients' compound motor action potential amplitudes in the masseter and temporalis muscles will be evaluated before interventions.

Time frame: at the beginning of the study

Studies using electromyography and complex muscle action potentials

All patients' compound motor action potential amplitudes in the masseter and temporalis muscles will be evaluated after two month of interventions.

Time frame: by the end of successful two month of intervention

Visual analogue scale (VAS)

All the participants were instructed to express their pain by Visual analogue scale (VAS) before the interventions.

Time frame: at the beginning of the study

Visual analogue scale (VAS)

All the participants were instructed to express their pain by Visual analogue scale (VAS) after two month of interventions.

Time frame: by the end of successful two month of intervention

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.